+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Ceapro Inc (CZO) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 53 Pages
  • June 2023
  • GlobalData
  • ID: 4302709
Ceapro Inc (CZO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - Analyst's summarization of the company's business strategy.
  • SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ceapro Inc (Ceapro) is a biotechnology company that focuses on the development and commercialization of extracts and active ingredients from oats and other renewable plant resources. The company's extracts are used in nutraceutical, cosmeceutical, and therapeutics products for personal, cosmetics, humans, and animals. Ceapro's natural active ingredients include avenanthramides, oat beta glucan, oat oil, oat peptides, oat powder and lupin peptides; natural anti-aging skincare products, and veterinary products include ear cleanse, oat shampoo and dermal complex/conditioner. The company uses its proprietary Pressurized Gas eXpanded (PGX) technology for extraction of active ingredients. It markets its products through distribution partners, subsidiaries and directly to final consumers. The company offers products in Canada, the US, China, Germany, Japan, Europe, India, and other countries. Ceapro is headquartered in Edmonton, Alberta, Canada.

Ceapro Inc Key Recent Developments

  • May 25, 2023: Ceapro reports financial results for first quarter 2023 and provides corporate update
  • Apr 27, 2023: Ceapro appoints Michel Regnier as Senior Vice President, Technical Operations
  • Apr 12, 2023: Ceapro Inc. Reports Record 2022 Financial Results and Operational Highlights
  • Mar 23, 2023: Ceapro announces data from research collaboration with McMaster University to be presented at the 2023 American Thoracic Society (ATS) International Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Ceapro Inc - Key Facts
  • Ceapro Inc - Key Employees
  • Ceapro Inc - Key Employee Biographies
  • Ceapro Inc - Major Products and Services
  • Ceapro Inc - History
  • Ceapro Inc - Company Statement
  • Ceapro Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Ceapro Inc - Business Description
  • Geographical Segment: Canada
  • Performance
  • Geographical Segment: China
  • Performance
  • Geographical Segment: Germany
  • Performance
  • Geographical Segment: Other
  • Performance
  • Geographical Segment: The US
  • Performance
  • R&D Overview
  • Ceapro Inc - Corporate Strategy
  • Ceapro Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Ceapro Inc - Strengths
  • Ceapro Inc - Weaknesses
  • Ceapro Inc - Opportunities
  • Ceapro Inc - Threats
  • Ceapro Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Ceapro Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 25, 2023: Ceapro reports financial results for first quarter 2023 and provides corporate update
  • Apr 27, 2023: Ceapro appoints Michel Regnier as Senior Vice President, Technical Operations
  • Apr 12, 2023: Ceapro Inc. Reports Record 2022 Financial Results and Operational Highlights
  • Mar 23, 2023: Ceapro announces data from research collaboration with McMaster University to be presented at the 2023 American Thoracic Society (ATS) International Conference
  • Mar 08, 2023: Ceapro announces data from research collaboration with the angiogenesis foundation to be presented at the 2023 Annual Meeting of the Wound Healing American Society
  • Jan 10, 2023: Ceapro to Present at the Virtual Investor 2023 Companies to Watch Event
  • Dec 23, 2022: Health Canada grants clearance for Ceapro’s anti-inflammatory therapy trial
  • Nov 09, 2022: Ceapro Inc. Reports 2022 Third Quarter and Nine-Month Financial Results and Operational Highlights
  • Aug 24, 2022: Ceapro Reports Record 2022 Second Quarter and Six-Month Financial Results and Provides Corporate Update
  • Aug 12, 2022: Ceapro and McMaster extend partnership to develop Covid-19 therapy
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Ceapro Inc, Key Facts
  • Ceapro Inc, Key Employees
  • Ceapro Inc, Key Employee Biographies
  • Ceapro Inc, Major Products and Services
  • Ceapro Inc, History
  • Ceapro Inc, Subsidiaries
  • Ceapro Inc, Key Competitors
  • Ceapro Inc, Ratios based on current share price
  • Ceapro Inc, Annual Ratios
  • Ceapro Inc, Interim Ratios
  • Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Ceapro Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Ceapro Inc, Performance Chart (2018 - 2022)
  • Ceapro Inc, Ratio Charts
  • Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Ceapro Inc, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Eurofins Alphora
  • Nymox Pharmaceutical Corp
  • Aptose Biosciences Inc
  • Microbix Biosystems Inc
  • Sernova Corp
  • Medicamen Biotech Ltd
  • Medicamen Biotech Ltd
  • Aptose Biosciences Inc
  • Microbix Biosystems Inc
  • Generex Biotechnology Corp
  • Nymox Pharmaceutical Corp
  • Sernova Corp
  • Eurofins Alphora